1338226-12-2 Usage
General Description
2,4-dibromo-3-(3-chloro-5-iodophenoxy)pyridine is a chemical compound with the molecular formula C11H6Br2ClIN2O. It is a pyridine derivative that contains bromine, chlorine, and iodine atoms, as well as a phenoxy group. 2,4-dibromo-3-(3-chloro-5-iodophenoxy)pyridine is commonly used as a building block in organic synthesis and medicinal chemistry, where it can be incorporated into various pharmaceuticals and agrochemicals. Its unique structure and functional groups make it a valuable intermediate for the development of new compounds with potential biological activity. Additionally, its bromine and iodine atoms can be utilized for the preparation of radiolabeled compounds for use in imaging studies and research.
Check Digit Verification of cas no
The CAS Registry Mumber 1338226-12-2 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,3,8,2,2 and 6 respectively; the second part has 2 digits, 1 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 1338226-12:
(9*1)+(8*3)+(7*3)+(6*8)+(5*2)+(4*2)+(3*6)+(2*1)+(1*2)=142
142 % 10 = 2
So 1338226-12-2 is a valid CAS Registry Number.
1338226-12-2Relevant articles and documents
Discovery of MK-1439, an orally bioavailable non-nucleoside reverse transcriptase inhibitor potent against a wide range of resistant mutant HIV viruses
C?té, Bernard,Burch, Jason D.,Asante-Appiah, Ernest,Bayly, Chris,Bédard, Leanne,Blouin, Marc,Campeau, Louis-Charles,Cauchon, Elizabeth,Chan, Manuel,Chefson, Amandine,Coulombe, Nathalie,Cromlish, Wanda,Debnath, Smita,Deschênes, Denis,Dupont-Gaudet, Kristina,Falgueyret, Jean-Pierre,Forget, Robert,Gagné, Sébastien,Gauvreau, Danny,Girardin, Melina,Guiral, Sébastien,Langlois, Eric,Li, Chun Sing,Nguyen, Natalie,Papp, Rob,Plamondon, Serge,Roy, Amélie,Roy, Stéphanie,Seliniotakis, Ria,St-Onge, Miguel,Ouellet, Stéphane,Tawa, Paul,Truchon, Jean-Fran?ois,Vacca, Joe,Wrona, Marc,Yan, Youwei,Ducharme, Yves
, p. 917 - 922 (2014/02/14)
The optimization of a novel series of non-nucleoside reverse transcriptase inhibitors (NNRTI) led to the identification of pyridone 36. In cell cultures, this new NNRTI shows a superior potency profile against a range of wild type and clinically relevant,
